Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Expression of ultralong complementarity determining region 3 and development of IgM and IgG B cell receptor repertoires in Holstein heifer calves.
PMID 41588676 · PMC12857222 · ImmunoHorizons · 2026 · 7 claims · 6 setups
The percentage of productive IgM sequences with ultralong CDR3 significantly increases between day 90 and ~day 285 of life
-
Full-text index only
Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients.
PMID 15312778 · PMC7127270 · Journal of molecular biology · 2004 · 8 claims · 7 setups
ORF3a of SARS-CoV encodes an actual 31 kDa, 274-residue protein detected in infected cells and virions
-
Full-text index only
Novel dengue virus type 1 from travelers to Yap State, Micronesia.
PMID 16494770 · PMC3373118 · Emerging infectious diseases · 2006 · 8 claims · 5 setups
DENV-1 responsible for the 2004 Yap State dengue outbreak was isolated from serum of 4 Japanese travelers returning from Yap
-
Full-text index only
α4 Integrin blockade impairs CD8+ T cell neuroimmune surveillance following SIV infection.
PMID 41734020 · PMC13078879 · The Journal of clinical investigation · 2026 · 8 claims · 8 setups
α4 blockade preserves CD4+ Th1 cell access to brain parenchyma but impairs CD8 effector recruitment, disrupting antiviral control
-
Full-text index only
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
PMID 18778482 · PMC2563025 · Retrovirology · 2008 · 8 claims · 7 setups
Intra-host nucleotide diversity of the HIV-2 C2V3C3 region increases over the course of chronic infection in most patients
-
Full-text index only
Development of a potent monoclonal antibody for treatment of human metapneumovirus infections.
PMID 41680141 · PMC13013820 · Nature communications · 2026 · 8 claims · 8 setups
4F11 is a highly potent neutralizing mAb against HMPV with in vitro and in vivo efficacy